Jing Xu1, Corey S Davis2, Marisa Cruz3, Peter Lurie4. 1. US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA. Electronic address: Jing.Xu@fda.hhs.gov. 2. Network for Public Health Law, 3701 Wilshire Blvd. #750, Los Angeles, CA, 90010, USA. Electronic address: cdavis@networkforphl.org. 3. US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA. Electronic address: Marisa.Cruz@fda.hhs.gov. 4. Center for Science in the Public Interest, 1220 L St. N.W., Suite 300, Washington, DC, 20005, USA. Electronic address: plurie@cspinet.org.
Abstract
BACKGROUND: In response to the ongoing opioid overdose epidemic, many states have enacted laws increasing naloxone access by lay people, such as friends and family members of people who use drugs (PWUD), as well as PWUD themselves. METHOD: We utilized Symphony Health Solutions' PHAST Prescription data from 2007 to 2016 to investigate whether naloxone access laws were associated with an increase in naloxone dispensed from retail pharmacies in the United States. RESULT: Using a negative binomial regression, we found that naloxone access laws were associated with an average increase of 78 prescriptions dispensed per state per quarter. This represents an average 79% increase in naloxone dispensed from U.S. retail pharmacies, compared with states where there were no such laws. CONCLUSION: Our study suggests that naloxone access laws can increase the availability and accessibility of naloxone.
BACKGROUND: In response to the ongoing opioid overdose epidemic, many states have enacted laws increasing naloxone access by lay people, such as friends and family members of people who use drugs (PWUD), as well as PWUD themselves. METHOD: We utilized Symphony Health Solutions' PHAST Prescription data from 2007 to 2016 to investigate whether naloxone access laws were associated with an increase in naloxone dispensed from retail pharmacies in the United States. RESULT: Using a negative binomial regression, we found that naloxone access laws were associated with an average increase of 78 prescriptions dispensed per state per quarter. This represents an average 79% increase in naloxone dispensed from U.S. retail pharmacies, compared with states where there were no such laws. CONCLUSION: Our study suggests that naloxone access laws can increase the availability and accessibility of naloxone.
Authors: Patricia R Freeman; Emily R Hankosky; Michelle R Lofwall; Jeffery C Talbert Journal: Drug Alcohol Depend Date: 2018-08-30 Impact factor: 4.492
Authors: Mandy L Renfro; Leticia R Moczygemba; Jennifer Baumgartner; Glen Baumgart; Lucas G Hill Journal: Am J Pharm Educ Date: 2020-10 Impact factor: 2.047
Authors: Minji Sohn; Jeffery C Talbert; Chris Delcher; Emily R Hankosky; Michelle R Lofwall; Patricia R Freeman Journal: Health Serv Res Date: 2020-02-07 Impact factor: 3.402
Authors: Bradley D Stein; Christopher M Jones; Rosanna Smart; Flora Sheng; Mark Sorbero Journal: Drug Alcohol Depend Date: 2021-02-03 Impact factor: 4.492
Authors: Traci C Green; Corey Davis; Ziming Xuan; Alexander Y Walley; Jeffrey Bratberg Journal: Am J Public Health Date: 2020-04-16 Impact factor: 9.308